The favorable dynamics for the Biotechnology industry is attracting investor attention. On the heels of recent gains, there are reasons to be optimistic on continued out-performance. An efficient Food and Drug Administration, progress on extension of new products, trouble in ‘major pharma’ land and reasonable valuation create a favorable milieu for investing in the biotechnology sector. These conditions… Read More »
MoneyMatters Blog
"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies."
Sam Subramanian PhD, MBA, Editor, AlphaProfit MoneyMatters
New ETF and Mutual Fund Recommendations
New ETF and Mutual Fund Recommendations
The Fidelity and ETF Core and Focus model portfolios have gained at annualized rates of 15.5% and 18.6%, respectively since 1994. The model portfolios will be repositioned with new mutual fund and ETF recommendations on Thursday, June 30. Learn more about AlphaProfit's Free and Premium Service investment newsletters.
Free Investment Newsletter MoneyMatters
- Independent analysis of the economy, markets, and sectors
- Unbiased ETF, stock, and mutual fund advice and evaluations
- Unique insights on emerging profit opportunities and must-know threats
- Complimentary access to premium service
- Subscription discounts for premium service
- Five Smart Ways of Using Sector Funds and ETFs with inside scoop on sector investments
- Three Key Mistakes to Avoid when Investing in Sector ETFs
Premium Service Investment Newsletter
Clear, Actionable Advice on Sectors, Funds, ETFs, & Stocks
- Specific guidance on what and when to buy or sell
- Long-term investing and short-term trading recommendations
- Proven strategies for all markets
- 75% win-rate including 2008 crash and dot-com bust
Market-beating model portfolios
- Suitable for small and large accounts sizes
- Appropriate for different investment objectives and account types
- Results verifiable in login area with free account
- Track record of smashing market 7-to-1
Priceless intangibles
- All recommendations provided ahead of time with ample notice
- Unbiased, independent advice with no axes to grind
- 24/7 access to premium service and its archives
- Access to Dr. Sam Subramanian via e-mail
THE GOOD NEWS JUST BEGINS!
